CONSEQUENCES OF HEPATORENAL TOXICITY INDUCED BY GENTAMICIN IN CHICKENS

Abstract

Gentamicin, one of aminoglycosides, was greatly used in treatment of different bacterial infections in animal. This study investigated the hepato-nephrotoxicity induced by single intramuscular (IM) injection gentamicin in chickens. A total number of 90, one day-old, Balady chicks were randomly divided into 3 groups each with 30 birds. Group (1) served as a control; Group (2) was given 25 mg gentamicin /kg body weight (BW), Group (3) was given 50 mg gentamicin /kg BW. Hepato-nephrotoxicity was evaluated by measuring growth performances, mortality rats, hematological parameters, biochemical markers; reduced glutathione (GSH), nitric oxide (NO), liver function tests, serum urea and creatinine levels, as well as, by evaluation of histopathological pictures of liver and kidney. 50 mg gentamicin /kg BW reduced growth performance and decreased red blood cell (RBC) count, hemoglobin (Hb) concentration, mean corpuscular hemoglobin concentration (MCHC), total protein, albumin, globulin levels and albumin/ globulin (A/G) ratio. There were significant heterophilic leukocytosis and eosinophilia. Levels of alkaline phosphatase (ALP), aspartate aminotransferase (AST) and alanine aminotransferase (ALT), urea, creatinine, liver and kidney NO were increased, meanwhile levels of GSH were decreased. Severe congestion, hemorrhage and multifocal coagulative necrotic areas were microscopically detected in liver and kidneys.Gentamicin injection altered hematological, biochemical and serum antioxidants pictures and induced hepatic and renal lesions in a dose dependent manner. The chickens administered 50 mg/kg BW gentamicin were more severely affected than 25 mg/kg BW gentamicin

Keywords


Assiut University web-site: www.aun.edu.eg

 

CONSEQUENCES OF HEPATORENAL TOXICITY INDUCED BY GENTAMICIN

IN CHICKENS

 

NAGAH ARAFAT1; REHAM EL-SHAFEI2; WALAA AWADIN3; VERGINIA FARAG4 and

RASHA SALEH5

 

1 Department of Poultry Diseases, Faculty of Veterinary Medicine, Mansoura University, Egypt

2 Department of Pharmacology, Faculty of Veterinary Medicine, Mansoura University, Egypt

3 Department of Pathology, Faculty of Veterinary Medicine, Mansoura University, Egypt

4 Department of Clinical Pathology Faculty of Veterinary Medicine, Mansoura University, Egypt

5 Department of Physiology, Faculty of Veterinary Medicine, Mansoura University, Egypt

 

Received: 28 June 2017;       Accepted: 30 July 2017

 

 

ABSTRACT

 

Gentamicin, one of aminoglycosides, was greatly used in treatment of different bacterial infections in animal. This study investigated the hepato-nephrotoxicity induced by single intramuscular (IM) injection gentamicin in chickens. A total number of 90, one day-old, Balady chicks were randomly divided into 3 groups each with 30 birds. Group (1) served as a control; Group (2) was given 25 mg gentamicin /kg body weight (BW), Group (3) was given 50 mg gentamicin /kg BW. Hepato-nephrotoxicity was evaluated by measuring growth performances, mortality rats, hematological parameters, biochemical markers; reduced glutathione (GSH), nitric oxide (NO), liver function tests, serum urea and creatinine levels, as well as, by evaluation of histopathological pictures of liver and kidney. 50 mg gentamicin /kg BW reduced growth performance and decreased red blood cell (RBC) count, hemoglobin (Hb) concentration, mean corpuscular hemoglobin concentration (MCHC), total protein, albumin, globulin levels and albumin/ globulin (A/G) ratio. There were significant heterophilic leukocytosis and eosinophilia. Levels of alkaline phosphatase (ALP), aspartate aminotransferase (AST) and alanine aminotransferase (ALT), urea, creatinine, liver and kidney NO were increased, meanwhile levels of GSH were decreased. Severe congestion, hemorrhage and multifocal coagulative necrotic areas were microscopically detected in liver and kidneys.Gentamicin injection altered hematological, biochemical and serum antioxidants pictures and induced hepatic and renal lesions in a dose dependent manner. The chickens administered 50 mg/kg BW gentamicin were more severely affected than 25 mg/kg BW gentamicin.

 

Key words: Antioxidant, gentamicin, growth performance, hematology, histopathology.

 

 


INTRODUCTION

 

Aminoglycosides are commonly used to treat bacterial infections because of their low cost and limited antibiotic resistance. Gentamicin, one of aminoglycosides, is greatly used in treatment of different bacterial infections in both animal and human (Kang et al., 2013).

 

It is used on a large scale in poultry farm, which is active against different Gram negative and some gram positive bacteria. Gentamicin was given to poultry by intramuscular (IM) injection due to its poor absorption from digestive tract (Haritova et al., 2004).

 

 
   
 

 


Corresponding author: Dr. REHAM EL-SHAFEI

E-mail address:Dr_reham16@yahoo.com

Present address: Department of Pharmacology, Faculty of Veterinary Medicine, Mansoura University, Egypt.

In field cases of gentamicin toxicity of White Leghorn layer flocks, dehydration, emaciation, watery diarrhea, increased water intake and high mortality were clinically observed (Islam et al., 2011).

 

Experimentally, pathological effects of gentamicin have been reported in growing cockerels(Khan et al., 2008) and growing broilers (Javed et al., 2008). Those studies reported the safe dose of gentamicin as 10 mg/kg body weight (BW) in day old broilers (Saleemi et al., 2009) and in growing White Leghorn cockerels (Khan et al., 2008). Generally,gentamicin as all aminoglycosides could induce tubular nephrotoxicity (Ravi et al., 2015).

 

Earlier studies found that gentamicin could release iron from renal mitochondria and form an iron gentamicin complex that promotes the production of free radicals and reactive oxygen species (ROS) (Kovacset, 2012). ROS and increased oxidative stress appear to be implicated in the pathophysiology of gentamicin induced nephrotoxicity (Morales et al., 2010). Furthermore, reduced glutathione content is reduced in renal cortex (Sener et al., 2002).

 

Several studies showed that ROS involved in gentamicin -induced nephrotoxicity, as well as, it has been shown to enhance the generation of superoxide anion (O2), peroxynitriteanion (ONOO), hydrogen peroxide (H2O2), and hydroxyl radical (OH) from renal cortical mitochondria, which is responsible for increase lipid peroxidation and decrease antioxidant enzymes (Tavafi  and Ahmad,  2011).

 

Therefore, the aim of this study was to compare the effect of two different doses of gentamicin (25 & 50 mg/kg BW as a single IM injection) on growth performance and pathophysiological picture in chickens.

 

MATERIALS AND METHODS

 

Experimental Chickens and management

A total number of 90, one day-old, Balady chicks were maintained in cages, kept in well ventilated disinfected room under 24 hours lighting and were provided with a commercial starter, balanced ration free from any medication. The feed and water were offered ad-libitum to all birds throughout the experimental period. Animal procedures were performed in accordance with the recommendations of the ‘Guide for the Care and Use of Laboratory Animals’ approved by the Ethics Committee of the Faculty of Veterinary Medicine, Mansoura University.

 

Drug (Gentamicin)

Ato-Gent 10%® (Injectable solution: each 1 ml contains gentamicin sulfate 156.25 mg equivalent gentamicin base 100 mg, Atcopharma, Egypt. Registration No 2265/2004, Batch No 419202. It was administrated on 21st day of age at the rate of 25 and 50 mg/kg BW as a single IM injection in pectoral muscles.

 

Experimental design

The 90 Balady chicks were randomly divided into 3 groups, each with 30 birds of two replicate. The treatment regimen was: Group (1) was served as control negative (injected with normal saline in pectoral muscles). Group (2) was given gentamicin 25 mg/kg BW as a single IM injection in pectoral muscles. Group (3) was given a single IM injection of gentamicin 50 mg/kg BW in pectoral muscles (Javed et al., 2013).

 

Sampling:

Blood samples were randomly gathered from the wing veins of five birds at the end of 1st day, 3rd day, 1stweek and 3rd weeks post gentamicin injection, and were immediately divided into two separate tubes. One of them was left in a plain test tube at room temperature for 1 hour and then centrifuged for 10 minutes at 3000 g to obtain the serum. The clear serum was stored in epindorf tubes at -20°C for subsequent biochemical analysis. The other blood sample was collected with ethylene diamine tetra acetic acid (EDTA) (0.5 mg/ ml blood) for hematological examination.

 

Random 3 birds from each group were sacrificed at 1st and 3rd weeks post gentamicin injection. Each bird was weighed prior to killing and tissue specimens from liver and kidney were collected then washed with ice-cold normal saline. Slices from liver and kidney were used to prepare tissue homogenates (10% weight/volume) in phosphate buffered saline (pH 7.4) using ultrasonic homogenizer (Cole-Parmer Instrument Company, USA). Then, the homogenates were centrifuged (4000 round per minute for 15 minutes at 4°C) and the supernatant was preserved at -80°C until used for antioxidant analysis. The remaining specimens were fixed in 10% buffered formaldehyde for histopathological examination.

 

Assessment of growth performance

Birds were weighed and feed intake per each group was measured weekly. Feed intake was determined for each group as the distinction between food supplied and the remaining food toward the end of every week. BW gain was figured as the difference between the final and the initial weight of the bird. FCR was calculated by dividing the amount of consumed feed (g) during the week by the gain in BW (g) during the same week (Smith, 1999).  

 

Relative organ weights

After killing, visceral organs (Liver, kidney, heart and spleen) were weighed and their relative weights were calculated as organ weight/ BW × 100.

 

Clinical signs, mortalities and gross lesions

 The birds were watched twice daily for three weeks post gentamicin injection until the end of the study for recording clinical signs and mortality. Gross lesions on different visceral organs were recorded for killed and dead birds.

 

Hematological analysis:

Red blood cells (RBC) and total leukocytic count (TLC) were manually performed according to Feldman et al. (2002) using improved neubauer haemocytometer Natt and Herrick solution according to Natt and Herrick (1952). Hemoglobin (Hb) concentration estimated spectrophotometrically next centrifugation using the cyanomethaemoglobin method, according to Dein (1984). Packed cell volume (PCV), mean corpuscular volume (MCV) (fL), mean corpuscular hemoglobin (MCH) (pg) and mean corpuscular hemoglobin concentration (MCHC) (%) were calculated by standard formula according to Feldman et al. (2002). The differential leukocytic count was made immediately by manual method (Andreasen and Latimer, 1990).

 

Serum biochemical analysis:

Frozen serum samples were subjected for estimation of alkaline phosphatase (ALP) (El tech, France), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) (Randox Co., UK), creatinine (Human, Germany), urea (Diamond, Egypt), total protein and albumin (Stanbio, USA). Globulin and albumin/globulin (A/G) ratio were calculated according (Kaneko et al., 1997).

 

Antioxidant analysis

Nitric oxide (NO) and reduced glutathione (GSH) were determined by enzymatic colorimetric method in liver and kidney extract using readymade kits provided by Bio-diagnostic, Egypt. The NO was estimated (Ignarro et al., 1987) based on the presence of nitrite in acid medium, the formed product was coupled with N-(1-naphthyl) ethylenediamine. GSH estimation was done according to the reduction of 5, 5 dithiobis (2-nitrobenzoic acid) (DTNB) with the glutathione producing a yellow product (Beutler et al., 1963).

 

Histopathology:

Liver and kidneys were collected from each bird during postmortem examination, fixed in 10% neutral buffered formalin and processed for histopathological examination by paraffin embedding method. Five µm thickness sections were cut and stained with hematoxylin and eosin according to Bancroft and Gamble, (2007).

 

Statistical analysis:

The data were statistically analyzed using SAS 9.2 for windows (SAS, 2004). The tests were used are one-way analysis of variance (ANOVA) and Duncan’s multiple-range tests. They were done for all hematological, biochemical and antioxidant parameters. The data were expressed as mean ± SD (P ≤ 0.05).

 

Results

Growth performance

The results showed that, growth performance parameters represented by mean body weight gain, average feed intake and FCR were significantly decreased in birds of both gentamicin treated Groups (2&3) when compared with control Group (1). However, the deleterious effect of 25 mg/kg BW gentamicin in Group (2) was less than 50 mg/kg BW gentamicin in Group (3) (Table 1).

 

Relative organs weight

There were significant increase in relative weights of liver, kidneys, heart and spleen in both gentamicin treated Groups (2&3) when compared with the control Group (1) at 1st and 3rd weeks post gentamicin injection.

 

Mortality rate, clinical signs and gross lesions

No clinical signs were observed in birds of Group (1) along the experimental period. Meanwhile, birds in Group (2) were slightly depressed. Birds in Group (3) showed sever clinical signs including depression, watery diarrhea, increased water intake and emaciation as shown in (Table 3). No mortalities were recorded in birds of Groups (1&2). No postmortem changes were found in Group (1) after 1st and 3rd weeks post gentamicin injection. Livers from dead and sacrificed birds after 1st week post gentamicin injection showed varying degrees of congestion, friableness and swelling in Groups (2&3) with ascending changes. At the 3rd week post gentamicin injection, the liver changes were more pronounced in Group (3) than in Group (2).Severe congestion and swelling in kidneys with distension of ureters with urates were shown only in Group (3). Meanwhile, slightly congested kidneys were seen in birds of Group (2).

 

Hematological results

At 1st and 3rd weeks post gentamicin injection, RBC, Hb and MCHC of Groups (2&3) were significantly decreased. Meanwhile, the MCV of Groups (2&3) was significantly increased when compared with Group (1) (Table 4).

 

Regarding to the leukogram, there was a significant heterophilic leukocytosis in Groups (2&3) at 1st and 3rd weeks post gentamicin injection. However, lymphopenia was recorded in Group (3) at 3rd week. Eosinophilia was significantly existed in the Group (3) only at 1st week post gentamicin injection (Table 5).

 

Biochemical results

Significant increases of AST, ALP and creatinine levels and decreases of total protein in Group (3) were prominent at all periods of the experiment and in Group (2) at 3rd week comparing with Group (1) as shown in (Table 6). In Groups (2&3), significant decrease of globulin (at 1st and 3rd day) and A/G ratio (at 1st and 3rd weeks post gentamicin injection) was observed comparing with Group (1). The urea level significantly increased in Groups (2&3) along the experimental period. The creatinine level significantly increased Group (3) along the experimental period and in Group (2) at 3rd day and 1st and 2nd week when compared with those of Group (1).

 

Antioxidant results

Significant increases of liver and kidney NO levels at 1st and 3rd weeks post gentamicin injection in Groups (2&3) when compared with Group (1) (Table 7). Liver GSH level significantly decreased in Groups (2&3) at 1st and 3rd weeks post gentamicin injection. Meanwhile, kidney GSH significantly decreased at 3rd week only when compared with the Group (1).      

 

Histopathological examination:

Liver showed normal shape and sizes of hepatocytes in Group (1) at two sacrifices. Liver from Group (2) at 1st and 3rd weeks post gentamicin injection showed vacuolar to hydropic degeneration, mild to severe congestion, perivascular edema and dilation of bile duct with hyperplasia of biliary epithelium. Few leukocytic cells infiltration was observed perivascular around hepatic blood vessels (Fig. 1). Liver from Group (3) at 1st week post gentamicin injection showed similar lesions to those observed in Group (2). At 3rd week post gentamicin injection, from Group (3) showed hemorrhage, perivascular fibrosis, new bile ductules formation and multifocal areas of coagulative necrosis in hepatic parenchyma (Fig. 2). Lymphocytic follicular aggregation was seen in the examined liver from all groups. However, the frequency and size of the follicles increased in liver from treated Groups 2&3 and in correspondence to duration of exposure(Fig. 3).

 

 Kidneys showed normal tubules and glomeruli in Group (1) in two sacrifices. At 1st week post gentamicin injection, kidneys from Groups (2&3) showed hydropic degeneration with detachment of renal epithelium from basement membrane, shrunken glomeruli and interstitial lymphocytic cells infiltration (Fig. 4). Similar lesions were observed in kidneys from Groups (2&3) at 3rd week post gentamicin injection with increased severity and distribution of lesions. Focal coagulative necrosis, congestion, perivascular edema, hemorrhage and degenerated glomeruli were additionally demonstrated in Group (3) at 3rd week post gentamicin injection (Fig. 5).

 

 

Table 1: Mean weight gain, average feed intake and Average feed conversation rate post gentamicin injection.

 

Groups

                                                     Parameter                           Weeks post                                       

                                    gentamicin     

                               Injection             

 

Group 3

 

Group 2

 

 

Group 1

65.5±0.69c

81.5±0.29b

93.5±1.4a

1

 Mean weight

gain (g)

85.7±1.1c

111.3±1.9b

148.8±2.6a

3

301.6±21.1c

350.4±25.3b

388.9±24.6a

1

Average feed

intake (g)

381.3±33.8c

444.1±35.3b

492.8±38.6a

3

4.6±0.38a

4.3±0.59b

4.16±0.32c

1

Average feed conversation rate (FCR)

4.45±0.50a

3.99±0.55b

3.31±0.44c

3

 

Different letters within the same row were significantly difference at P≤0.05.

 

Table 2: Relative organs weights post gentamicin injection. 

 

Groups

Organ                         Weeks post                                       

                                    gentamicin     

                               Injection

Group 3

Group 2

Group 1

4.22±0.31a

3.4±0.26b

2.72±0.14c

1

Liver          

 

6.94±0.41a

4.92±0.31b

2.9±0.16c

3

1.31±0.1a

0.91±0.06b

0.62±0.01d

1

Kidney        

1.6±0.13a

0.93±0.11b

0.59±0.02d

3

0.69±0.01a

0.55±0.03b

0.32±0.03d

1

Heart          

0.82±0.02a

0.51±0.04b

0.31±0.02c

3

0.13±0.01a

0.095±0.01b

0.08±0.01b

1

Spleen          

0.14±0.05b

0.097±0.03b

0.082±0.01a

3

 

Different letters within the same row were significantly difference at (P≤0.05).

 


Table 3: Mortality rate and clinical signs of different groups post Gentamicin injection.

 

Groups

Weeks post Gentamicin injection

Parameter

3

2

1

50mg/kg Gentamicin

25mg/kg Gentamicin

Control

5

0

0

0

0

0

1

3

Numbers of

mortalities

5/30

(16.6)a

 

0/30

(0.0)b

 

0/30

(0.0)b

 

1 &3

 

Number of dead/total numbers   (%)

10

0

2

0

0

0

1

3

Numbers of birds with clinical signs*

10/30

(33.3)a

2/30

(6.6)b

0/30

(0.0)b

 

1&3

Number of diseased /total numbers (%)

* Clinical signs are represented by depression, watery diarrhea, increased water intake, and emaciation.

Different letters within the same row were significantly difference at (P≤0.05).

 

Table 4: Erythrogram of different groups post gentamicin injection.

 

Groups

RBC

(106/µl)

Hb

(g/dl)

PCV

(%)

MCV

(fl)

MCH

(pg)

MCHC

(%)

Week 1

Group 1

3.24 ± 0.39a

7.97 ±0.85a

38.91 ± 0.79a

121.31 ± 16.88b

24.63 ± 1.62a

20.48 ± 2.18a

Group 2

2.28 ± 0.38b

5.23 ± 0.96b

33.76 ± 1.27a

150.55 ± 24.75ab

22.99 ± 2.91a

15.54 ± 3.23b

Group 3

2.15 ± 0.43b

5.56 ± 0.95b

36.40 ± 6.81a

169.73 ± 7.39a

26.39 ± 1.0a

15.56 ± 0.41b

Week 3

Group 1

3.30  ± 0.36a

7.49 ± 0.54a

39.45 ± 2.53a

120.04 ± 7.43b

22.90 ± 2.99a

19.07 ± 2.14a

Group 2

2.28 ± 0.37b

5.62 ± 0.92b

39.57 ± 2.23a

175.80 ± 22.02a

25.13 ± 5.89a

14.18 ± 1.82b

Group 3

2.41 ± 0.08b

5.25 ± 0.50b

40.74 ± 1.42a

169.03 ± 10.56a

21.80 ± 2.76a

12.88 ± 1.16b

 

Means with different superscript letters (a, b) in the same vertical column are significantly different at p ≤0.05.

 

Table 5: Leukogram of different groups post gentamicin injection.

Groups

TLC
103/µl

Lymphocytes
103/µl

Heterophils
103/µl

Monocytes
103/µl

Eosinophils

103/µl

Basophils
 103/µl

Week 1

Group 1

12.00 ± 2.00b

6.99 ± 2.44a

4.51 ± 1.20b

0.29 ± 0.12a

0.11 ± 0.10b

0.11 ± 0.10a

Group 2

19.33 ± 3.06a

8.03 ± 0.20a

10.73 ± 3.09a

0.31 ± 0.27a

0.20 ± 0.22ab

0.07 ± 0.12a

Group 3

20.67 ± 3.06a

7.60 ± 0.88a

12.68 ± 4.06a

0.56 ± 0.18a

0.49 ± 0.20a

0.13 ± 0.23a

Week 3

Group 1

13.33 ± 1.15b

8.39 ± 0.71a

4.26 ± 0.33b

0.41 ± 0.16a

0.23 ± 0.09a

0.05 ± 0.08 a

Group 2

21.33 ± 4.16a

8.39 ± 0.23a

12.59 ± 4.17a

0.36 ± 0.16a

0.0 ± 0.0 a

0.0 ± 0.0 a

Group 3

20.67 ± 3.06a

5.23 ± 0.93b

14.91 ± 2.64a

0.34 ± 0.30a

0.19 ± 0.18a

0.0 ± 0.0 a

 

Means with different superscript letters (a, b) in the same vertical column are significantly different at p ≤0.05.

 

Table 6: Some serum biochemical profiles of different groups post gentamicin injection

Creatinine  (mg/dl)

 

Urea

(mg/dl)

A/G

(ratio)

Globulin

(g/dL)

Albumin

(g/dL)

T.P.

(g/dL)

ALP

(µ/L)

ALT

(µ/L)

AST

(µ/L)

Groups

Day 1

0.58 ±

0.04 b

5.33 ±

2.25 b

0.39 ±

0.01 a

5.10 ±

0.34 a

1.97 ±

0.10 a

7.08 ±

0.43 a

135.7 ±

68.3 b

17.60 ±

3.09 a

19.13 ±

4.80 b

Group 1

1.29 ±

0.34 b

14.33 ±

0.58 a

0.49 ±

0.23 a

3.12 ±

0.81 b

1.43 ±

0.56 a

4.55 ±

0.85 b

889.5 ± 489.9 b

18.77 ±

6.05 a

22.40 ±

2.16 b

Group 2

5.15 ±

3.32 a

14.67 ±

3.79 a

1.08 ±

0.62 a

1.72 ±

1.37 b

1.38 ±

0.32 a

3.10 ±

1.61 b

1952.9 ± 688.0 a

21.55 ±

7.02 a

53.80 ± 25.30 a

Group 3

Day 3

0.65 ±

0.16 b

7.79 ±

2.29 b

0.45 ±

0.24 a

5.10 ±

1.55 a

2.04 ±

0.37 a

7.14 ±

1.20 a

116.1 ±

24.7 c

13.09 ±

5.11 b

11.98 ±

2.34 b

Group 1

1.82 ±

0.38 a

11.43 ±

1.25 a

0.98 ±

0.12 a

2.18 ±

0.62 b

2.09 ±

0.41 a

4.28

± 1.01 b

1046.9 ± 701.2 b

23.24 ±

1.98 a b

28.88 ±

7.69 b

Group 2

2.37 ±

0.85 a

11.82 ±

1.66 a

1.57 ±

1.18 a

1.60 ±

0.63 b

2.03 ±

0.62 a

3.63

± 0.52 b

1946.1 ± 229.2 a

29.09 ±

8.45 a

72.82 ± 15.61 a

Group 3

Week 1

 

0.57±

0.12b

9.43 ±

1.0b

1.13 ±

0.18 a

1.78 ±

0.35 a

1.98 ±

0.22a

3.76 ±

0.50a

235.0 ± 743.2c

16.40 ±

3.12 a

14.07 ± 6.27b

Group 1

1.14 ±

0.21b

16.28 ±

3.35a

0.80 ±

0.16b

1.59 ±

0.27a

1.23 ±

0.05b

2.82 ±

0.22b

743.2 ± 75.8b

22.49 ±

478a

39.09 ±

10.58 a b

Group 2

2.81 ±

1.20a

17.14 ±

2.57a

0.71 ±

0.05 b

1.27 ±

0.22a

0.90 ±

0.12c

2.16 ±

0.33b

964.7 ± 96.1a

24.43 ± 3.53a

63.00 ± 37.03a

Group 3

Week 3

 

0.58 ±

0.06b

9.05 ±

0.69b

1.10 ±

0.29 a

2.02 ±

0.43a

2.16 ±

0.42a

4.18 ±

0.59a

238.4 ± 53.9b

8.96 ±

2.69b

10.01 ± 1.39c

Group 1

1.23 ±

0.29ab

15.04 ± 1.11a

0.60 ±

0.08 b

1.81 ±

0.48 a

1.06 ±

0.18b

2.87 ±

0.65b

656.5 ± 43.4a

17.25 ±

3.31a

19.31 ± 0.86b

Group 2

2.35 ±

1.07a

16.80 ±

1.51a

0.59 ±

0.09 b

1.53 ±

0.30 a

0.89 ±

0.12b

2.42 ±

0.38b

764.3 ±

81.0a

17.28 ±

2.54a

28.20 ±

4.41a

Group 3

 

GSH Liver

GSH Kidney

NO Kidney

NO Liver

Groups

Week 1

3.62 ± 0.41a

1.36 ± 1.16  a

16.67 ± 1.15 b

24.13 ± 0.40 b

Control

1st group

2.12 ± 0.13b

1.27 ± 0.26 a

40.53 ± 0.65 a

59.73 ± 0.68 a

2nd group

1.42 ± 0.43 b

1.53 ± 0.60 a

40.77 ± 1.51 a

61.83 ± 3.18 a

3rd group

Week 3

3.72 ± 0.41 a

2.48 ± 0.22 a

15.40 ± 0.72 b

24.40 ± 0.62 c

Control

1st group

1.66 ± 0.14 b

0.95 ± 0.08 b

45.27 ± 4.70 a

65.80 ± 0.20 b

2nd group

0.71 ± 0.13 c

0.82 ± 0.09 b

49.63 ± 1.01 a

71.17 ± 1.30 a

3rd group

Means with different superscript letters (a, b, c) in the same vertical column are significantly different at p 0.05.

 

Table 7: Levels of GSH and NO in liver and kidney of different groups post gentamicin injection

 

 

Means with different superscript letters (a, b, c) in the same vertical column are significantly different at p 0.05.

 

 

 

 

Fig.1: liver shows normal shape and sizes of hepatocytes in Group (1) (A), vacuolar degeneration in hepatocytes with small sized vacuoles (black lines) in Group (2) at 1st week post gentamicin injection (B), diffuse hydropic degeneration in hepatocytes (black lines) with few perivascular leukocytic cells infiltration (arrow) (C), perivascular edema (arrowhead) and dilation of bile duct with hyperplasia of biliary epithelium (arrow) in Group (2) at 3rd week post gentamicin injection (D) (arrow) (H&E, A- C: x 200 and D: x 100).

 

 

 

Fig. 2: Liver in Group (3) at 3rd week post gentamicin injection shows new bile ductule formation (arrow) (A), perivascular fibrosis (arrows) (B), focal area of coagulative necrosis (arrow) (C&D). (H&E A&D: x 200, B&C: x 100).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 3: Liver shows different sizes of lymphocytic aggregation (arrow) (A-C) in Groups (1 to 3), respectively (H&E A-C: x 100).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fig. 4: Kidney shows normal tubules and glomeruli in Group (1) (A), shrunken glomeruli (arrowheads), separation of renal epithelium from basement membrane (arrows) (B), hydropic degeneration in renal tubules (arrows)  (C) and focal lymphocytic cells infiltration in interstitial tissue (thick arrow) (D)  of Group (2) one week post gentamicin injection (H&E x 200).

 

 

Fig.5: Kidney of Group (3) three weeks post gentamicin injection shows severe hydropic degeneration in renal tubules (arrows), shrunken glomerulus (arrowhead) (A), lymphocytic cells aggregation in renal parenchyma (thick arrow), degenerated glomerulus (arrowhead), hemorrhage (thin arrow) (B), perivascular edema and hemorrhage (arrow) (C) and focal coagulative necrosis in some renal tubules (arrows) (D) (H&E x 200).

 


DISCUSSION

 

There are many cases of unexplained nephritis; hepatitis and high mortality were reported in poultry farms, which might be due to using the nephrotoxic substances such as gentamicin. Because of the extensive use of gentamicin in our Egyptian poultry farms, we were encouraged to correlate between clinical signs, biochemical alterations and pathological changes induced by gentamicin in chickens.

 

Chickens administered gentamicin 50 mg/kg showed a significant decrease in growth performance throughout the experiment and this was due to anorexia and depression following gentamicin administration. Similar results were recorded by Javed et al. (2015)who showed that gentamicin at level 50 mg/ kg BW in broilers resulted in severe clinical signs and 33.33 % mortalities. These observations were in line with earlier studies in day old broiler chicks and commercial white leghorn layers (Saleemi et al., 2009). In addition, Islam et al. (2011) observed dehydration, emaciation, watery diarrhea, increased water intake and high mortality in field cases of gentamicin toxicity in White Leghorn layer flocks.

 

Clinical signs and mortalities in this study were more obvious in injected chickens with gentamicin at level 50 mg/kg BW suggesting this level was toxic for chickens. The safe dose of gentamicin was 10 mg/kg BW in day old broilers (Saleemi et al., 2009) and in growing White Leghorn cockerels (Khan et al., 2008).

 

Normal erythrogram picture indicated normal erythropoitic tissue and adequate requirements (Coles, 1986). Gentamicin in Groups (2&3) revealed two types of anemia, normocytic normochromic and normocytic hypochromic anemia respectively at 1st week. This anemia changed to macrocytic hypochromic type (after two weeks), which may be attributed to the reduced erythropoietin hormone and enhanced RBC fragility consequence to gentamicin injection (Nagano et al., 1990). The erythropoietin inhibition in the renal cortex altered the basic hematological parameters in rats (Kalaidjieva and Iliev, 2000). In addition, the present uremia inhibited the erythropoiesis and led to intravascular hemolysis (Hostetter and Andreasen, 2004). Moreover, the present heterophilic leukocytosis and eosinophilia indicated the inflammatory response to gentamicin (Irizarry-Rovira et al., 2006). The hematological results were in harmony with results of Saleemi et al. (2009)and established by elevation of NO and depression of GSH levels of the present results. The NO had a critical cellular function, besides a potent mediator of cellular damage (Pacher et al., 2007). In this study, gentamicin significantly increased the oxidative stress that was clear from increased total oxidant status in Groups (2&3) more than in Group (1)agreeing with Haritova et al. (2004); Islam et al. (2011); ELazab and EL-Habashi (2015). Regarding to the gentamicin elimination route, it accumulated in the renal proximal tubular cells through the megalin/cubilin complex receptor, which is responsible for carrying gentamicin inside the cell (Said, 2011). Several studies showed that the ROS involved in gentamicin -induced nephrotoxicity, as well as, it has been shown to enhance the generation of superoxide anion (O2ˉ), peroxynitriteanion (ONOO), hydrogen peroxide (H2O2), and hydroxyl radical (OH) from renal cortical mitochondria, which is responsible for increase lipid peroxidation and decrease antioxidant enzymes (Tavafi and Ahmad, 2011). Regarding to the effect of gentamicin on the tested biochemical parameters, this study revealed an elevation in levels of AST, ALT, ALP, urea, creatinine and lowering in total protein, albumin and A/G ratio while globulin was normal. The decreased A/G ratio was related to inflammation nephropathy and liver damage caused by gentamicin injection. However, AST, ALT and ALP enzymes were not specific for liver disease in birds but they increased with liver damage (Harr, 2002).Liver enzymes indicated the alteration in cell membrane integrity or biliary epithelium (Eran et al., 2007). Urea was a nitrogenous waste product formed in the liver and execrated via kidneys (Kaneko, 2008). Albumin was formed in liver, lost in glomerulonephritis but the globulin could be normal. Hypoalbuminemia was an independent predictor for acute renal injury and death. Creatinine investigated kidney disease and could not influence by liver or urea cycle (Harr, 2002). Many previous reports showed the decrease in TP and albumin levels and increase in ALT and creatinine levels in chicken injected with gentamicin (Saleemi et al., 2009).Its effect extended to cause severe nephrotoxic and hepatotoxic effects (Javed et al., 2015). Generally,gentamicin as all aminoglycosides induced tubular nephrotoxicity (Khan et al., 2008).This may bebecause gentamicin after removal from the blood accumulated in renal tubular cells and produced phospholipidosis (Beauchamp et al., 1991).

 

 Microscopically, injection of gentamicin induced pathological lesions in growing cockerels (Kaneko, 2008) and growing broilers (Khan et al., 2008). Our results revealed severe degenerative and necrotic changes accompanied with multifocal lymphocytic inflammation were observed in liver and kidneys from chicken injected with 50 mg gentamycin /kg BW. Kidney and liver injuries followed by gentamicin administration could be the major reasons for anorexia, decrease in growth performance and subsequent emaciation of the birds. These data agreed with previous findings obtained by Sundin et al. (2001) who mentioned that gentamicin caused inhibition of protein synthesis, resulting in proximal tubule cell necrosis in renal cells in 13–30 % of treated patients. This mechanism specifically caused proximal tubule cells necrosis, resulting in acute tubular necrosis that can lead to acute renal failure.

 

Conclusion

Gentamicin administration reduced growth performance, altered hematological, biochemical and serum antioxidants pictures and induced hepatic and renal lesions that appeared to be dose dependent.The chicken administered 50 mg/kg BW gentamicin as a single IM dose was more severely affected than 25 mg/kg BW gentamicin.

 

Conflict of interest

The authors declare that there is no conflict of interest.

 

Funding sources

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

 

Abbreviations:

BW, Body weight; IM, intramuscular; NO, Nitric oxide; GSH, reduced glutathione; ROS, Reactive Oxygen Species; FCR, Feed conversion ratio; RBC, Red blood cells; TLC, total leukocytic count; Hb, hemoglobin; PCV, packed cell volume; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; A/G, albumin/globulin; O2, superoxide anion; ONOO, peroxynitriteanion; H2O2, hydrogen peroxide; OH, hydroxyl radical; EDTA, ethylene diaminetetra acetic acid; ALP, alkaline phosphatase; AST, aspartate aminotransferase; ALT, alanine aminotransferase.

 

Acknowledgment

We acknowledge support of Departments; Poultry diseases, Pharmacology, Pathology, Physiology and Clinical Pathology, Mansoura University for providing chemicals, instruments and devices.

 

Author contribution

 Nagah Arafat: putting the study plan,running the experimental schedule, measuring feed and growth parameters, collecting samples and sharing in writing. Reham El-Shafei: sharing the study plan, sharing collecting samples, sharing in writing, revising and submission of the article as a corresponding author. Walaa Awadin: histopathological evaluation, sharing in writing and revising of the manuscript. Verginia Farag: Sharing in collecting samples, writing, revision and measuring serum biochemical parameters, leukogram and erythrogram. Rasha Saleh: measuring antioxidant parameters

REFERENCES

 

Andreasen, CB. and Latimer, KS. (1990):Separation of avian heterophils from blood using Ficoll–Hypaque discontinuous gradients. Avian Dis. 33, 163–167.

Bancroft, JD. and Gamble, M. (2007): Theory and Practice of Histological Techniques. 5th Ed; Churchill Livingstone, London, UK, pp: 125-138.

Beauchamp, D.; Gourde, P. and Bergeron, MG. (1991): Subcellular distribution of Gentamicin in proximal tubular cells. Antimicrob.Agents Chemother. 35: 2173–2179.

Beutler, E.; Duron, O. and Kelly, BM. (1963):Improved method for the determination of blood glutathione. J. lab. Clin. Med. 61: 882-888.

Coles, EH. (1986): Veterinary Clinical Pathology Forth edition W.B. Saunders Co. Philadelphia. 40, pp: 222-225.

Dein, FJ. (1984): Laboratory Manual of Avian Haematology. Association of Avian Veterinarian, East north port, USA.

ELazab, MF. and EL-Habashi, N. (2015): Gentamicin-induced nephrotoxicity in chickens: Modulatory role of Moringa oleifera.  Assiut Vet. Med. J. 61 (144).

Eran, E.; Galia, P.; Rifaat, S. and Orit, P. (2007): Association between consumption of Herbalife® nutritional supplements and acute hepatotoxicity. J. Hepatol. 47: 514–520.

Feldman, BF.; Zinkl, JG.; Jain, NC. and Gasper, P. (2000):Schalm's Veterinary Hematology. Wiley.

Haritova,AM.; Djeneva,HA.; Lashev,L.; Sotirova,PG.; Gurov,BI. and Dyankov, VN. (2004): Pharmacokinetics of gentamicin and apramycin in turkeys roosters and hens in the context of pharmacokinetic–pharmacodynamic relationships. J. Vet. Pharm. Ther. 27:381-384.

Harr, KE. (2002): Clinical chemistry of companion avian species: a review. Vet. Clin. Pathol. 31, 140–151.

Hostetter, SJ. and Andreasen, CB. (2004): General Principles. In: COWELL, R.L. Veterinary clinical pathology secrets. Missouri: Elsevier, pp: 1–3.

Ignarro, LJ.; Buga, GM.; Wood, KS.; Byrns, RE. and Chaudhuri, G. (1987): Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 84: 9265–9269.

Irizarry-Rovira, AR.; Wolf, A. and Ramos- Vara, JA. (2006):Cutaneous melanophoroma in a green iguana (Iguana iguana). Vet. Clin. Pathol. 35: 101-105.

Islam, NU.; Khan, MZ.; Khan, MK.; Saleemi, A.; Khan, SA.; Bhatti, M.; Yousaf, M. and Hassan, ZU. (2011): Clinicopathological studies on gentamicin toxicity in White Leghorn commercial layers. Pak. Vet. J. 31: 305– 308.

Javed, S.; Khan, JA.; Khaliq, K.; Javed, I. and Abbas, RZ. (2015): Experimental evaluation of nephroprotective potential of Calotropis procera (Ait) flowers against Gentamicin -induced toxicity in albino rabbits.  Pak. Vet. J. 35(2): 222-226.

Javed, U.; Khan, MZ.; Saleemi, MK.; Khan, A.; Javed, I. and Rafique, S. (2013): Toxico- Pathological effects of Parenteral administration of gentamicin in growing broilers. Int. J. Agric. Biol., 15: 529-534.

Javed, U.; Saleemi, MK.; Khan, MZ.; Khan, A. and Javed, I. (2008): Pathological effects of Gentamicin in growing broilers. Proc 15th Congress of FAVA-OIE Joint Symposium on Emerging Diseases, pp: 17-18.

Kalaidjieva, VC. and Iliev, ZK. (2000): Plasma erythropoietin level in rats after kidney proximal tubular impairment. Folia Med. 42: 41-45.

Kaneko, JJ. (2008): Hepatic function. In: JJ Kaneko, JW Harvey and ML Bruss (eds), Clinical Biochemistry of Demostic Animals, 6th Edition, (EAcedemic Press, London), pp: 356-365.

Kaneko, JJ.; Harvey, JW. and Bruss, ML. (1997): Clinical biochemistry of domestic animals, 4th Edition.

Kang, C.; Lee, DY.; Hah, JH.; Heo, CH.; Kim, E. and Kim, JS. (2013): Protective effects of Houttuynia  cordata Thunb on gentamicin - induced oxidative stress and nephrotoxicity in rats. Toxicol.  Res. 29: 61-67.

Khan, I.; Khan, MZ.; Saleemi, MK.; Javed, I. and Khan, A. (2008): Pathological and biochemical effects of intramuscular gentamicin administration in chicken. Turk. J. Vet. Anim. Sci. 32: 345-351.

Kovacs, E.; Savopol, T.; Iordache, MM.; Saplacan, L.; Sobaru, I.; Istrate, C.; Mingeot-Leclercq, MP. and Moisescu, MG. (2012): Interaction of gentamicin polycation with model and cell membranes. Bioelectrochem. (Amsterdam, Netherlands) 87: 230–235.

Morales, AI.; Detaille, D.; Prieto, M.; Puente, A.; Briones, E.; Arévalo, M.; Leverve, X.; López- Novoa, JM. and El-Mir, MY. (2010): Metformin prevents experimental Gentamicin - induced nephropathy by a mitochondria- dependent pathway. Kidney Int. 77: 861-869.

Nagano, K.; Kamiyama, T.; Nakao, M. and Nakao, K. (1990): A direct relationship between adenosine triphosphate-level and in vivo viability of erythrocytes. Nature 194:877-87852.

Natt, MP. and Herrick, CA. (1952): A new blood diluent for counting erythrocytes and leucocytes of the chicken. Poultry Sci. 31, 735–738.

Pacher, P.; Beckman, JS. and Liaudet, L. (2007): Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315–424.

Ravi, K.; Vamsi, K. and Boobalan, G. (2015): Adverse effects of routinely used drugs in animal husbandry practice. Eggers P. Prevalence of chronic kidney disease in the United States. J. Am. Med. Assoc.298(17): 2038–47.

Said, MM. (2011):The protective effect of eugenol against gentamicin induced nephrotoxicity and oxidative damage in rat kidney. Fundam. Clin. Pharmacol. 25:708–716.

Saleemi, MK.; Khan, MZ.; Khan, A. and Javed, I. (2009): Pathological effects of gentamicin administered intramuscularly today old broiler chicks. Exp. Toxicol. Path. 61: 425-432.

SAS Institute (2004): SAS Users Guide Statistics version, SAS Institute Inc., Cary, NC-USA.

Sener, G.; Sehirli, A.; Altunbas, O.; Ersoy, HZ.; Paskaloglu, Y.; Arbak, K. and Ayanoglu-Dulger, G. (2002): Melatonin protects against gentamicin-induced nephrotoxicity in rats. J. Pineal Res. 32, 231–236.

Smith, T. (1999): Commercial broiler production. Mississippi State University, Mississippi State, MS. Chapter 2, pp: 7-13.

Sundin, DP.; Sandoval, R. and Molitoris, BA. (2001): Gentamicin inhibits renal protein and phospholipid metabolism in rats: implications involving intracellular trafficking. J. Am. Soc. Nephrol. 12:114–123.

Tavafi, M. and Ahmad, H. (2011): Effect of rosmarinic acid on inhibition of gentamicin induced nephrotoxicity in rats. Tissue Cell 43:392–397.

 

 

 

عواقب التسمم الکبدى الکلوي بالجنتاميسين في الدجاج

نجاح عرفات , ريهام أحمد الشافعي , ولاء فکرى , فيرجينيا محمد المتولى , رشا محمد صالح

Email: Dr_reham16@yahoo.com    Assiut University web-site: www.aun.edu.eg

 

يستخدم الجنتاميسين، کأحد الأمينوجلوکوسيدات في علاج الالتهابات البکتيرية المختلفة في الحيوان. لقد أجريت هذه الدراسة لبحث تأثير التسمم الکبدى الکلوى الناجم عن جرعتين مختلفتين من دواء الجنتاميسين في الدجاج .حيث تم تقسيم عدد تسعين کتکوت عمر يوم واحد إلى ثلاث مجموعات بکل منها 30 کتکوت. المجموعة (1) کانت بمثابة المجموعة الضابطه. أعطيت المجموعة (2) جنتاميسين 25 ملجم / کجم من وزن الجسم حقن عضل مره واحده, أعطيت المجموعة (3) حقن عضل مره واحدة من الجنتاميسين 50 ملجم / کجم من وزن الجسم. وقد تم تقييم السمية الکبدية الکلوية من خلال قياس معدلات النمو ، نسبة الوفيات ، المعاملات الدموية و البيوکيميائية و GSH الجلوتاثايون المختزل وأکسيد النتريک و اختبارات وظائف الکبد و مستويات اليوريا والکرياتينين في الدم، وکذلک تم فحص الصورة النسيجية المکروسکوبيه للکبد والکلى. وقد ادت جرعة 50 ملحم/کجم من وزن الجسم من الجينتاميسين الي خفض أداء النمو وتغيير معظم القياسات المختبرية ، مما أدى إلى انخفاض عدد کرات الدم الحمراء والهمجلوبين والبروتين الکلي ومستويات الجلوبيولين ونسبة (A/G) الالبومين الى الجلوبيبولين  کان هناک عدد کبير من الکريات البيضاء والخلايا المتعادلة و خلايا الاسينوفيل. تم زيادة مستويات AST، ALP  و اليوريا والکرياتينين. وزيادة مستويات أکسيد النيتريک للکبد والکلى وخفض مستويات GSH. تم الکشف عن احتقان شديد، ونزف، ومناطق نخر متجلط متعددة البؤر في الکبد والکلى. وبذلک نجد ان حقن الجنتاميسين ادى الى تغيرات فى صورة الدم والصورة البيوکيميائية ومضادات الأکسدة وتسببت بتغيرات باثولوجية فى الکبد والکلى وذلک يعتمد على تغيير الجرعة حيث کانت الکتاکيت التي حقنت ب 50 ملجم / کجم من وزن الجسم جنتاميسين أکثر تأثرا من التي حقنت ب 25 ملجم / کجم من وزن الجسم جنتاميسين.

 

 

 

 

 

 

 

 

Andreasen, CB. and Latimer, KS. (1990):Separation of avian heterophils from blood using Ficoll–Hypaque discontinuous gradients. Avian Dis. 33, 163–167.
Bancroft, JD. and Gamble, M. (2007): Theory and Practice of Histological Techniques. 5th Ed; Churchill Livingstone, London, UK, pp: 125-138.
Beauchamp, D.; Gourde, P. and Bergeron, MG. (1991): Subcellular distribution of Gentamicin in proximal tubular cells. Antimicrob.Agents Chemother. 35: 2173–2179.
Beutler, E.; Duron, O. and Kelly, BM. (1963):Improved method for the determination of blood glutathione. J. lab. Clin. Med. 61: 882-888.
Coles, EH. (1986): Veterinary Clinical Pathology Forth edition W.B. Saunders Co. Philadelphia. 40, pp: 222-225.
Dein, FJ. (1984): Laboratory Manual of Avian Haematology. Association of Avian Veterinarian, East north port, USA.
ELazab, MF. and EL-Habashi, N. (2015): Gentamicin-induced nephrotoxicity in chickens: Modulatory role of Moringa oleifera.  Assiut Vet. Med. J. 61 (144).
Eran, E.; Galia, P.; Rifaat, S. and Orit, P. (2007): Association between consumption of Herbalife® nutritional supplements and acute hepatotoxicity. J. Hepatol. 47: 514–520.
Feldman, BF.; Zinkl, JG.; Jain, NC. and Gasper, P. (2000):Schalm's Veterinary Hematology. Wiley.
Haritova,AM.; Djeneva,HA.; Lashev,L.; Sotirova,PG.; Gurov,BI. and Dyankov, VN. (2004): Pharmacokinetics of gentamicin and apramycin in turkeys roosters and hens in the context of pharmacokinetic–pharmacodynamic relationships. J. Vet. Pharm. Ther. 27:381-384.
Harr, KE. (2002): Clinical chemistry of companion avian species: a review. Vet. Clin. Pathol. 31, 140–151.
Hostetter, SJ. and Andreasen, CB. (2004): General Principles. In: COWELL, R.L. Veterinary clinical pathology secrets. Missouri: Elsevier, pp: 1–3.
Ignarro, LJ.; Buga, GM.; Wood, KS.; Byrns, RE. and Chaudhuri, G. (1987): Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 84: 9265–9269.
Irizarry-Rovira, AR.; Wolf, A. and Ramos- Vara, JA. (2006):Cutaneous melanophoroma in a green iguana (Iguana iguana). Vet. Clin. Pathol. 35: 101-105.
Islam, NU.; Khan, MZ.; Khan, MK.; Saleemi, A.; Khan, SA.; Bhatti, M.; Yousaf, M. and Hassan, ZU. (2011): Clinicopathological studies on gentamicin toxicity in White Leghorn commercial layers. Pak. Vet. J. 31: 305– 308.
Javed, S.; Khan, JA.; Khaliq, K.; Javed, I. and Abbas, RZ. (2015): Experimental evaluation of nephroprotective potential of Calotropis procera (Ait) flowers against Gentamicin -induced toxicity in albino rabbits.  Pak. Vet. J. 35(2): 222-226.
Javed, U.; Khan, MZ.; Saleemi, MK.; Khan, A.; Javed, I. and Rafique, S. (2013): Toxico- Pathological effects of Parenteral administration of gentamicin in growing broilers. Int. J. Agric. Biol., 15: 529-534.
Javed, U.; Saleemi, MK.; Khan, MZ.; Khan, A. and Javed, I. (2008): Pathological effects of Gentamicin in growing broilers. Proc 15th Congress of FAVA-OIE Joint Symposium on Emerging Diseases, pp: 17-18.
Kalaidjieva, VC. and Iliev, ZK. (2000): Plasma erythropoietin level in rats after kidney proximal tubular impairment. Folia Med. 42: 41-45.
Kaneko, JJ. (2008): Hepatic function. In: JJ Kaneko, JW Harvey and ML Bruss (eds), Clinical Biochemistry of Demostic Animals, 6th Edition, (EAcedemic Press, London), pp: 356-365.
Kaneko, JJ.; Harvey, JW. and Bruss, ML. (1997): Clinical biochemistry of domestic animals, 4th Edition.
Kang, C.; Lee, DY.; Hah, JH.; Heo, CH.; Kim, E. and Kim, JS. (2013): Protective effects of Houttuynia  cordata Thunb on gentamicin - induced oxidative stress and nephrotoxicity in rats. Toxicol.  Res. 29: 61-67.
Khan, I.; Khan, MZ.; Saleemi, MK.; Javed, I. and Khan, A. (2008): Pathological and biochemical effects of intramuscular gentamicin administration in chicken. Turk. J. Vet. Anim. Sci. 32: 345-351.
Morales, AI.; Detaille, D.; Prieto, M.; Puente, A.; Briones, E.; Arévalo, M.; Leverve, X.; López- Novoa, JM. and El-Mir, MY. (2010): Metformin prevents experimental Gentamicin - induced nephropathy by a mitochondria- dependent pathway. Kidney Int. 77: 861-869.
Nagano, K.; Kamiyama, T.; Nakao, M. and Nakao, K. (1990): A direct relationship between adenosine triphosphate-level and in vivo viability of erythrocytes. Nature 194:877-87852.
Natt, MP. and Herrick, CA. (1952): A new blood diluent for counting erythrocytes and leucocytes of the chicken. Poultry Sci. 31, 735–738.
Pacher, P.; Beckman, JS. and Liaudet, L. (2007): Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315–424.
Ravi, K.; Vamsi, K. and Boobalan, G. (2015): Adverse effects of routinely used drugs in animal husbandry practice. Eggers P. Prevalence of chronic kidney disease in the United States. J. Am. Med. Assoc.298(17): 2038–47.
Said, MM. (2011):The protective effect of eugenol against gentamicin induced nephrotoxicity and oxidative damage in rat kidney. Fundam. Clin. Pharmacol. 25:708–716.
Saleemi, MK.; Khan, MZ.; Khan, A. and Javed, I. (2009): Pathological effects of gentamicin administered intramuscularly today old broiler chicks. Exp. Toxicol. Path. 61: 425-432.
SAS Institute (2004): SAS Users Guide Statistics version, SAS Institute Inc., Cary, NC-USA.
Smith, T. (1999): Commercial broiler production. Mississippi State University, Mississippi State, MS. Chapter 2, pp: 7-13.
Sundin, DP.; Sandoval, R. and Molitoris, BA. (2001): Gentamicin inhibits renal protein and phospholipid metabolism in rats: implications involving intracellular trafficking. J. Am. Soc. Nephrol. 12:114–123.
Tavafi, M. and Ahmad, H. (2011): Effect of rosmarinic acid on inhibition of gentamicin induced nephrotoxicity in rats. Tissue Cell 43:392–397.